4//SEC Filing
Piscitelli Dominic 4
Accession 0001415889-25-016739
CIK 0001796280other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 6:37 PM ET
Size
8.1 KB
Accession
0001415889-25-016739
Insider Transaction Report
Form 4
Piscitelli Dominic
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-06-10$10.00/sh−324$3,240→ 105,093 total - Sale
Common Stock
2025-06-11$10.01/sh−1,700$17,017→ 102,117 total - Sale
Common Stock
2025-06-11$10.00/sh−1,276$12,760→ 103,817 total
Footnotes (2)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024.
- [F2]Includes an aggregate of 1,553 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.
Documents
Issuer
Oric Pharmaceuticals, Inc.
CIK 0001796280
Entity typeother
Related Parties
1- filerCIK 0001695028
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 6:37 PM ET
- Size
- 8.1 KB